B.1.617.2 enters and fuses lung cells with increased efficiency
Por um escritor misterioso
Descrição
The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.617.2, emerged in India and has spread to over 80 countries. B.…
SARS-CoV-2 requires acidic pH to infect cells
Full article: Virus-induced senescence: A therapeutic target to mitigate severe progression of SARS-COV-2
Frontiers Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study - eBioMedicine
Omicron subvariant BA.5 efficiently infects lung cells
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics, Virology Journal
Delta variant exhibits immune evasion, enhanced cell entry, and augmented syncytium formation
Covid-19: virology, variants, and vaccines
Deutsches Primatenzentrum: Delta and Delta Plus evade the antibody response
The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
de
por adulto (o preço varia de acordo com o tamanho do grupo)
